Oncolytics Biotech buy Canaccord Genuity Group Inc.
Start price
06.03.23
/
50%
€1.61
Target price
06.03.24
€4.69
Performance (%)
-
End price
07.03.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oncolytics Biotech | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Oncolytics Biotech diskutieren
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for ONCY provided by MarketBeat
In the thread Trading Oncolytics Biotech
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten